LSV Asset Management lessened its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC – Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 179,700 shares of the company’s stock after selling 24,000 shares during the quarter. LSV Asset Management’s holdings in Phibro Animal Health were worth $6,714,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. 1620 Investment Advisors Inc. raised its position in Phibro Animal Health by 77.4% during the fourth quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company’s stock valued at $25,000 after acquiring an additional 295 shares in the last quarter. Farther Finance Advisors LLC raised its position in Phibro Animal Health by 113.2% during the fourth quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock valued at $27,000 after acquiring an additional 386 shares in the last quarter. Hughes Financial Services LLC bought a new position in Phibro Animal Health during the third quarter valued at approximately $40,000. iSAM Funds UK Ltd bought a new position in Phibro Animal Health during the third quarter valued at approximately $61,000. Finally, EverSource Wealth Advisors LLC raised its position in Phibro Animal Health by 7,671.4% during the second quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock valued at $69,000 after acquiring an additional 2,685 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on PAHC. Zacks Research lowered shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 21st. Weiss Ratings lowered shares of Phibro Animal Health from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 8th. Wall Street Zen lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Citigroup cut their price objective on shares of Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating on the stock in a research report on Thursday, May 14th. Finally, Morgan Stanley set a $49.00 price target on Phibro Animal Health in a report on Friday, February 6th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Phibro Animal Health has an average rating of “Hold” and a consensus target price of $38.80.
Phibro Animal Health Stock Up 1.3%
Phibro Animal Health stock opened at $33.68 on Wednesday. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of 14.45, a P/E/G ratio of 0.50 and a beta of 0.61. The company has a debt-to-equity ratio of 1.97, a current ratio of 3.17 and a quick ratio of 1.26. Phibro Animal Health Corporation has a fifty-two week low of $22.85 and a fifty-two week high of $60.08. The firm has a fifty day moving average price of $49.66 and a two-hundred day moving average price of $45.90.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. The firm had revenue of $383.54 million during the quarter, compared to analyst estimates of $367.02 million. Phibro Animal Health had a net margin of 6.35% and a return on equity of 37.14%. Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. As a group, analysts forecast that Phibro Animal Health Corporation will post 3.07 earnings per share for the current year.
Phibro Animal Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 24th. Shareholders of record on Wednesday, June 3rd will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 3rd. This represents a $0.48 dividend on an annualized basis and a yield of 1.4%. Phibro Animal Health’s payout ratio is currently 20.60%.
Insiders Place Their Bets
In other news, CEO Jack Bendheim sold 10,560 shares of the firm’s stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $52.68, for a total value of $556,300.80. Following the sale, the chief executive officer owned 80,360 shares in the company, valued at approximately $4,233,364.80. This trade represents a 11.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last three months, insiders have sold 81,968 shares of company stock worth $4,395,532. 50.13% of the stock is owned by insiders.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.
The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.
Featured Stories
- Five stocks we like better than Phibro Animal Health
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC – Free Report).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
